Anne Marie Lane, MPH

Research Summary

Research Summary

Ms. Lane is an epidemiologist and biostatistician in the Ocular Melanoma Center. She oversees the Mass. Eye and Ear Uveal Melanoma Registry, which is a resource to better understand melanoma risk, identify biomarkers of melanoma incidence and progression, and evaluate outcomes after treatment. The ultimate goal of this research is to develop treatment strategies that will conserve visual function and improve patient survival.


1979: A.B., Anthropology, Harvard College

1991: M.P.H., Epidemiology, Yale University School of Medicine

Academic Appointments

2014-present: Lecturer on Ophthalmology, Harvard Medical School

2005-2014: Instructor in Ophthalmology, Harvard Medical School

2004-2005: Research Associate in Ophthalmology, Harvard Medical School

Professional Memberships

Association for Research in Vision and Ophthalmology (ARVO)


Selected Publications

For a full publication list, please see her CV.

  1. Lane AM, Kim IK, Gragoudas ES. Survival rates in patients after treatment for metastasis from uveal melanoma. JAMA Ophthalmol. 2018;136(9):981-986.
  2. Papakostas TD, Morrison MA, Lane AM, Awh C, DeAngelis MM, Gragoudas ES, Kim IK. Genetic risk factors for radiation vasculopathy. Invest Ophthalmol Vis Sci. 2018; 59:1547-53.
  3. Gupta MP, Lane AM, DeAngelis MM, Mayne K, Crabtree M, Gragoudas ES, Kim IK. Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations. JAMA Ophthalmol. 2015; 133:881-7
  4. Lane AM, Egan KM, Kim IK, Gragoudas ES. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010; 128:996-1000.
  5. Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009; 116:2206-2212.

View a complete list of publications on>>